< Back to Article
Multitarget inhibition of CDK2, EGFR, and tubulin by phenylindole derivatives: Insights from 3D-QSAR, molecular docking, and dynamics for cancer therapy
Fig 7
Docking simulation of the interaction between (A) Ligand Pred9, (B) Ligand Pred10 and
(C) Erlotinib (reference drug) with EGFR protein.
doi: https://doi.org/10.1371/journal.pone.0326245.g007